In this double-blind study, we have allocated randomly Different fade characteristics have been described with various non-depolarizing neuromuscular blocking drugs. At onset of neuromuscular block, gallamine is associated with more fade in the train-offour (TOF) than pancuronium [1] or vecuronium [2] . Similarly, tubocurarine is associated with more fade than pancuronium [3] . For individual blocking drugs, fade differs between onset and offset of block. The neuromuscular block produced by either vecuronium or gallamine has been shown to have more fade during recovery of block than during onset [2] .
Different fade characteristics have been described with various non-depolarizing neuromuscular blocking drugs. At onset of neuromuscular block, gallamine is associated with more fade in the train-offour (TOF) than pancuronium [1] or vecuronium [2] . Similarly, tubocurarine is associated with more fade than pancuronium [3] . For individual blocking drugs, fade differs between onset and offset of block. The neuromuscular block produced by either vecuronium or gallamine has been shown to have more fade during recovery of block than during onset [2] .
In this double-bind study, we have sought to make a pharmacodynamic comparison of the neuromuscular effects of vecuronium and atracurium at the manufacturers' recommended doses on the U.S. data sheets.
METHODS AND RESULTS
After approval from the Human Investigation Committee, 40 consenting patients (ASA I-III) aged 18-65 yr were allocated randomly to one of four groups: group 1 = vecuronium 0.08 mg kg" 1 ; group 2 = vecuronium 0.1 mg kg" 1 ; group 3 = atracurium 0.4 mg kg" 1 ; group 4 = atracurium 0.5 mg kg" 1 . Patients taking medication or with medical conditions known to interact with neuromuscular transmission were excluded. The study drug was prepared in a blinded manner immediately before surgery. Patients were premedicated orally with ranitidine 150 mg and metoclopramide 10 mg 2 h before operation and diazepam 5-10 mg 1 h before operation. A rapidly running i.v. infusion of Ringer's lactate solution was commenced and a Datex neuromuscular monitor attached for electromyographic analysis of the TOF response at the hypothenar eminence after stimulation of the ulnar nerve at the distal forearm.
Anaesthesia was induced with fentanyl 2-5 ng kg" 1 followed by thiopentone 4-6 mg kg"
1
. The lungs were ventilated via a face mask with 1-2 % inspired isoflurane and nitrous oxide in oxygen while the neuromuscular monitor was calibrated and a baseline supramaximal response obtained. The neuromuscular blocking drug was administered over 5 s. Anaesthesia was maintained with 0.5-0.75 % inspired isoflurane and 60 % nitrous oxide in oxygen (monitored with a mass spectrometer). The TOF response was recorded every 20 s throughout surgery.
During onset of neuromuscular block, the T4:T1 ratio was measured when Tl had decreased to 50% of baseline. During recovery from neuromuscular block, we compared the T4:T1 ratio when Tl recovered to 25 % of baseline.
Results are presented as mean (SD). Data were analysed statistically with unpaired Student's t test.
Mean age was 42 yr (range 18-65 yr), weight 70 (12) kg and height 168 (8) cm (ns between groups).
Time to maximum Tl depression from the injection of the myoneural blocker was faster (within dose group) after vecuronium compared with atracurium, although this was only significant in the higher dose comparison (vecuronium: 3.5 (0.8) min, atracurium: 5.6 (2.2) min; P < 0.05). Time from administration of the agent to the return of Tl to 25 % of baseline was almost identical within dose groups (atracurium: 32.7 (8.3) min, vecuronium: 30.5 (8.8) min for the smaller doses; atracurium: 49.0 (8.7) min, vecuronium: 49.7 (15.6) min for the larger doses).
During the onset of neuromuscular block, the T4:T1 ratio was smaller with atracurium than with vecuronium (table I) . During recovery of Tl to 25%, the reappearance of T4 was delayed markedly in the patients receiving vecuronium compared with patients receiving atracurium (table I) .
COMMENT
The doses of atracurium and vecuronium used in this study had a similar duration of action. However, the faster speed of onset with vecuronium may be clinically useful and may also allow a smaller dose of vecuronium to be given, resulting in a shorter duration of action compared with atracurium. This finding is similar to that of a previous study [4] , but differs from another which demonstrated a faster onset time for atracurium [5] . Such differences in speed of onset may be accounted for by the doses of blocking drug used, the end-points measured (e.g. time from injection to maximum effect, time for Tl to decrease from 75% to 25% or 95% to 5% of baseline) the method of measurement (e.g. electromyogram or force transducer) and the muscle group studied. The apparent duration of action may be affected by factors such as the concentration of isoflurane used and the temperature of the muscles being stimulated. All our patients had their arms covered, but active warming was not used. Muscle uptake of isoflurane occurs slowly but continuously and is likely to influence the neuromuscular response increasingly over time. Methodological differences between studies make direct comparison difficult. It has been suggested that fade in the train-of-four results from block of prejunctional receptors at the neuromuscular junction. Normally, stimulation of these receptors results in transfer of acetylcholine (Ach) from storage sites to the readily available sites near the junctional membrane in preparation for rapid release. Therefore, in the presence of prejunctional block, rapidly repeated stimuli would result in decreasing amounts of Ach being released [6] .
Comparative studies have shown fade to differ between neuromuscular blocking agents [1] . Our study showed atracurium to have the most fade at onset when compared with vecuronium, a finding reported also in another study [5] .
Greater fade during offset compared with onset of action of vecuronium has been reported previously, and the importance of measuring fade at both these times stressed [2] . Following a bolus dose of neuromuscular blocker, there are rapidly changing concentrations of drug in the blood and at the sites of action. The time taken for the drug to penetrate through to, and bind to different receptors may result in differing pharmacodynamic effects during this early equilibration phase of block. Our finding may be explained by vecuronium having a greater affinity for the prejunctional receptor than atracurium, but being able to enter and leave the region of the prejunctional receptor only slowly, resulting in a slower onset and offset of prejunctional effects compared with atracurium. In contrast, atracurium would appear to attain its maximal, albeit relatively small, prejunctional effect rapidly. The fact that atracurium undergoes spontaneous degradation may further influence its action by bypassing the need for the drug to diffuse out of the region of the prejunctional receptors.
